These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20660852)

  • 21. New approaches to heart failure in the ED.
    Dakin CL
    Am J Nurs; 2008 Mar; 108(3):68-71. PubMed ID: 18316914
    [No Abstract]   [Full Text] [Related]  

  • 22. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

  • 23. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Troughton RW; Richards AM; Yandle TG; Nicholls G
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232832
    [No Abstract]   [Full Text] [Related]  

  • 24. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natriuretic cardiac hormones. Clinical use in heart failure].
    Nielsen SJ; Gøtze JP; Raymond IE; Grønning BA; Kirk V; Bay-Nielsen M; Hildebrandt PR; Aldershvile J
    Ugeskr Laeger; 2004 Jan; 166(4):248-53. PubMed ID: 14964102
    [No Abstract]   [Full Text] [Related]  

  • 28. Heart failure and B-type natriuretic protein.
    Hoyne J
    Clin Lab Sci; 2009; 22(4):233-9. PubMed ID: 19967919
    [No Abstract]   [Full Text] [Related]  

  • 29. Limited value of brain natriuretic peptide as a prognostic marker in acute heart failure--a meta-analysis.
    Binder A; Seropian IM; Kontos MC; Van Tassell BW; Biondi-Zoccai GG; Abbate A
    Int J Cardiol; 2010 Dec; 145(3):540-1. PubMed ID: 20541821
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain natriuretic peptide in heart failure.
    Aronow WS
    J Am Geriatr Soc; 2006 Feb; 54(2):368-9; author reply 369. PubMed ID: 16460396
    [No Abstract]   [Full Text] [Related]  

  • 32. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.
    Lamb EJ; Vickery S; Price CP
    J Am Coll Cardiol; 2006 Sep; 48(5):1060-1; author reply 1061. PubMed ID: 16949506
    [No Abstract]   [Full Text] [Related]  

  • 34. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma brain natriuretic peptide-guided therapy not yet justified.
    Hoppe UC
    J Am Coll Cardiol; 2007 Nov; 50(21):2097-8; author reply 2098-9. PubMed ID: 18021882
    [No Abstract]   [Full Text] [Related]  

  • 36. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
    Morello AM; Januzzi JL
    Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes and the endocrine heart.
    Christoffersen C; Hunter I; Jensen AL; Goetze JP
    Eur Heart J; 2007 Oct; 28(20):2427-9. PubMed ID: 17872916
    [No Abstract]   [Full Text] [Related]  

  • 38. Test opens window into the failing heart. A hormone made by an overworked or damaged heart offers important clues to heart function and new avenues for treatment.
    Harv Heart Lett; 2003 Jul; 13(11):6. PubMed ID: 12888478
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnosis of heart failure with the help of natriuretic peptides. Practical tool in primary health care].
    Theodorsson E
    Lakartidningen; 2001 Oct; 98(41):4427. PubMed ID: 11699247
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
    Glick A; Michowitz Y; Keren G; George J
    Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.